Description

CP10 combines two of the most extensively studied growth hormone research peptides, CJC-1295 Without DAC (Mod GRF 1-29) and Ipamorelin, in a precision-balanced 5mg + 5mg format. This dual-peptide combination is designed for researchers investigating synergistic growth hormone-releasing pathways through both GHRH and GHRP mechanisms simultaneously.

Each unit is third-party laboratory tested and supplied with a Certificate of Analysis (COA) confirming compound identity, purity, and consistency, essential standards for reliable and reproducible research outcomes.

Compound Overview

CJC-1295 Without DAC (Mod GRF 1-29) is a modified GHRH analog engineered for pulse-based growth hormone stimulation. Without the Drug Affinity Complex (DAC), this compound maintains a shorter half-life that closely mirrors the body’s natural pulsatile GH release pattern, making it a preferred choice for researchers requiring physiologically accurate GH stimulation data.

Ipamorelin is a highly selective GHRP-class pentapeptide and ghrelin receptor agonist. Recognized for its clean receptor selectivity, Ipamorelin stimulates growth hormone release without significantly affecting cortisol or prolactin levels, providing researchers with a precise and controlled GH release signal ideal for isolated pathway studies.